Publisher: Icon Group International, Inc.
Category: Oncology/Hematology

Oncology/Hematology market research reports by Icon Group International, Inc.

(361 reports matching your criteria)
    • The 2023-2028 World Outlook for Breast Cancer Diagnostic Products

      The 2023-2028 World Outlook for Breast Cancer Diagnostic Products This study covers the world outlook for breast cancer diagnostic products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2023-2028 World Outlook for Interventional Oncology Devices

      The 2023-2028 World Outlook for Interventional Oncology Devices This study covers the world outlook for interventional oncology devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2023-2028 World Outlook for External Beam Radiation Oncology Therapies

      The 2023-2028 World Outlook for External Beam Radiation Oncology Therapies This study covers the world outlook for external beam radiation oncology therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2023-2028 World Outlook for Liver Cancer Diagnostics

      The 2023-2028 World Outlook for Liver Cancer Diagnostics This study covers the world outlook for liver cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2023-2028 World Outlook for Interventional Oncology

      The 2023-2028 World Outlook for Interventional Oncology This study covers the world outlook for interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2023-2028 World Outlook for Embolization in Interventional Oncology

      The 2023-2028 World Outlook for Embolization in Interventional Oncology This study covers the world outlook for embolization in interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2023-2028 World Outlook for Oncology Information System Software

      The 2023-2028 World Outlook for Oncology Information System Software This study covers the world outlook for oncology information system software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2023-2028 World Outlook for Immune-Oncology Treatments

      The 2023-2028 World Outlook for Immune-Oncology Treatments This study covers the world outlook for immune-oncology treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2023-2028 World Outlook for Immuno Oncology Assays

      The 2023-2028 World Outlook for Immuno Oncology Assays This study covers the world outlook for immuno oncology assays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2023-2028 World Outlook for Alkylating Gynaecological Cancer Drugs

      The 2023-2028 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2023-2028 World Outlook for Anaplastic Thyroid Cancer Drugs

      The 2023-2028 World Outlook for Anaplastic Thyroid Cancer Drugs This study covers the world outlook for anaplastic thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2023-2028 World Outlook for Therapies and Diagnostics for Ovarian Cancers

      The 2023-2028 World Outlook for Therapies and Diagnostics for Ovarian Cancers This study covers the world outlook for therapies and diagnostics for ovarian cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2023-2028 World Outlook for Colorectal Cancer Treatments

      The 2023-2028 World Outlook for Colorectal Cancer Treatments This study covers the world outlook for colorectal cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2023-2028 World Outlook for Cancer Immunotherapy Monoclonal Antibodies

      The 2023-2028 World Outlook for Cancer Immunotherapy Monoclonal Antibodies This study covers the world outlook for cancer immunotherapy monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2023-2028 World Outlook for Cancer Biologics

      The 2023-2028 World Outlook for Cancer Biologics This study covers the world outlook for cancer biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2023-2028 World Outlook for Colorectal Cancer Drugs

      The 2023-2028 World Outlook for Colorectal Cancer Drugs This study covers the world outlook for colorectal cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2023-2028 World Outlook for Colorectal Cancer Chemotherapy Therapeutics

      The 2023-2028 World Outlook for Colorectal Cancer Chemotherapy Therapeutics This study covers the world outlook for colorectal cancer chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2023-2028 World Outlook for Cancer Immunotherapies

      The 2023-2028 World Outlook for Cancer Immunotherapies This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2023-2028 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing

      The 2023-2028 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing This study covers the world outlook for cancer immunotherapy drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More

    • The 2023-2028 World Outlook for Leukemia Therapeutics

      The 2023-2028 World Outlook for Leukemia Therapeutics This study covers the world outlook for leukemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2023-2028 World Outlook for Leukemia Chemotherapy Therapeutics

      The 2023-2028 World Outlook for Leukemia Chemotherapy Therapeutics This study covers the world outlook for leukemia chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2023-2028 World Outlook for Sarcoma Drugs

      The 2023-2028 World Outlook for Sarcoma Drugs This study covers the world outlook for sarcoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More

    • The 2023-2028 World Outlook for Breast Cancer Drugs

      The 2023-2028 World Outlook for Breast Cancer Drugs This study covers the world outlook for breast cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2023-2028 World Outlook for Cancer-Treating Drugs

      The 2023-2028 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2023-2028 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics

      The 2023-2028 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics This study covers the world outlook for chemotherapy and other multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More

7 8 9 10 11 12 13 14 15

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings